November 29, 2023 12:53
Samsung Biologics has racked up cumulative contracts worth a record W3.49 trillion this year (US$1=W1,294).
It is the first time that the biotech company has earned more than W3 trillion in annual deals.
Samsung announced Tuesday that it signed one new and four additional contract-manufacturing deals with a pharmaceutical company in Asia worth W760.8 billion, bringing the total amount this year to more than double last year's figure of W1.78 trillion.
The biotech company has done business with 14 out of the top 20 global pharmaceutical firms including AstraZeneca, Eli Lilly, GlaxoSmithKline, and Moderna.
- Copyright © Chosunilbo & Chosun.com